Plasma fibronectin concentrations in morbidly obese patients. 1984

A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud

Plasma fibronectin concentrations and liver morphology were investigated in 45 morbidly obese subjects (median overweight 88%) and in 42 normal weight controls, matched for sex and age. A significantly (P less than 0.01) raised plasma fibronectin concentration (median 464 mg/l, range 276-862 mg/l) was found in the obese subjects when compared with concentrations in the controls (median 348 mg/l, range 164-536 mg/l). Plasma fibronectin concentrations of the obese patients correlated significantly to their degree of overweight (r = 0.33, P less than 0.05) as well as to the degree of fatty change found in their liver biopsies (r = 0.33, P less than 0.05). Significantly (P less than 0.05) elevated plasma fibronectin concentrations even in obese subjects without hepatic fatty change indicate that liver fat accumulation is no prerequisite of the obesity-related elevation of plasma fibronectin. Raised plasma fibronectin concentration in obesity may more readily be explained by an increased fibronectin formation by lipocytes.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D005234 Fatty Liver Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS. Liver Steatosis,Steatohepatitis,Steatosis of Liver,Visceral Steatosis,Liver Steatoses,Liver, Fatty,Steatohepatitides,Steatoses, Liver,Steatoses, Visceral,Steatosis, Liver,Steatosis, Visceral,Visceral Steatoses
D005260 Female Females
D005353 Fibronectins Glycoproteins found on the surfaces of cells, particularly in fibrillar structures. The proteins are lost or reduced when these cells undergo viral or chemical transformation. They are highly susceptible to proteolysis and are substrates for activated blood coagulation factor VIII. The forms present in plasma are called cold-insoluble globulins. Cold-Insoluble Globulins,LETS Proteins,Fibronectin,Opsonic Glycoprotein,Opsonic alpha(2)SB Glycoprotein,alpha 2-Surface Binding Glycoprotein,Cold Insoluble Globulins,Globulins, Cold-Insoluble,Glycoprotein, Opsonic,Proteins, LETS,alpha 2 Surface Binding Glycoprotein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
February 1999, Obesity surgery,
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
March 1993, Medicina clinica,
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
July 2001, Internal medicine (Tokyo, Japan),
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
May 2003, The New England journal of medicine,
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
August 2007, Metabolism: clinical and experimental,
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
January 1982, La Ricerca in clinica e in laboratorio,
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
October 2001, Polskie Archiwum Medycyny Wewnetrznej,
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
April 2006, The Journal of clinical endocrinology and metabolism,
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
June 1997, American journal of hypertension,
A Dejgaard, and T Andersen, and P Christoffersen, and I Clemmensen, and C Gluud
October 1983, Scandinavian journal of clinical and laboratory investigation,
Copied contents to your clipboard!